1. 131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study 
Gregory A. Yanik, Judith G. Villablanca, John M. Maris, Brian Weiss, Susan Groshen, Araz Marachelian, Julie R. Park, Denice Tsao-Wei, Randall Hawkins, Barry L. Shulkin, Hollie Jackson, Fariba Goodarzian, Hiro Shimada, Jesse Courtier, Raymond Hutchinson, Daphne Haas-Koga, C. Beth Hasenauer, Scarlett Czarnecki, Howard M. Katzenstein, Katherine K. Matthay 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 4, Pages (April 2015)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
(A) EFS, based upon disease status at study entry: cohort 1 (primary refractory/PD) and cohort 2 (PR to induction). (B) OS, based upon disease status at study entry: cohort 1 (primary refractory/PD) and cohort 2 (PR to induction).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions